Globally active firm producing and distributing reagents for in-vitro molecular diagnostic testing seeks to acquire a controlling share in a company with successful operations in the development and production of biotechnologies and innovative solutions for modern clinical diagnostic needs.
Following the initial contact request, the applicant company will be asked to prepare a detailed information memorandum in English.